Item 2.02 Results of Operations and Financial Condition.

On August 10, 2021, Clearside Biomedical, Inc. (the "Company) issued a press release announcing its financial results for the quarter ended June 30, 2021, as well as information regarding a conference call to discuss these financial results and the Company's recent corporate highlights. A copy of this press release is furnished herewith as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

In accordance with General Instruction B.2. of Form 8-K, the information in this Item 2.02, and Exhibit 99.1 hereto, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any incorporation language in such a filing, except as expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.



(d) Exhibits



Exhibit
Number    Exhibit Description
99.1        Press Release, dated August 10, 2021
104       Cover Page Interactive Data File (embedded with the Inline XBRL document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses